KRAS and acute lymphoblastic leukemia: Detected from the ALL borderland cohort were ROS1, ATM, and KRAS; genes with the highest level of clinical significance that were found harboring variants with mutational significance in Tier 3, Tier X, and Tier 1, respectively (Figure 1).